Article

Immunogenicity evaluation of mutant peptides identified from lung cancer patients

2026-08-20

Abstract excerpt

<title>Abstract</title> <p> Tumor genome sequencing can identify genetic mutations that, when translated, lead to mutant peptides. Such mutant peptides, when shown to be immunogenic, may be designated as neoantigens. We identified three mutant peptides (PLVAP, MBOAT7, and Neurofascin) from lung cancer patients and characterized their antigenicity in this study. T cells and B cells were isolated from peripheral b...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 628c2435-ea82-5f24-9010-9d66489f5145
DOI: 10.21203/rs.3.rs-10635382/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Immunogenicity evaluation of mutant peptides identified from lung cancer patientsDOI 10.21203/rs.3.rs-10635382/v1Read

MHC class II restricted neoantigen peptides predicted by clonal mutation analysis in lung adenocarcinoma patients: implications on prognostic immunological biomarker and vaccine designSemantic proximity Read

In silico neoantigen screening and HLA multimer-based validation identify immunogenic neopeptide in multifocal lung adenocarcinoma.Semantic proximity Read

The Current Lung Cancer Neoantigen Landscape and Implications for Therapy.Semantic proximity Read

Mutation-Derived Neoantigens for Cancer ImmunotherapySemantic proximity Read

Can we predict mutant neoepitopes in human cancers for patient-specific vaccine therapy?Semantic proximity Read

Neoantigen-Based Immunotherapy in Lung Cancer: Advances, Challenges and ProspectsSemantic proximity Read

Harnessing Tumor Mutations for Truly Individualized Cancer VaccinesSemantic proximity Read

Tumor immunogenicity regulates host immune responses, and conventional dendritic cell type 2 uptakes the majority of tumor antigens in an orthotopic lung cancer model.Semantic proximity Read

Discovery and Subtyping of Neo-Epitope Specific T-Cell Responses for Cancer Immunotherapy: Addressing the Mutanome.Semantic proximity Read

Identification and evaluation of tumor pyroptosis-associated antigens for design a vaccine candidate against lung cancerSemantic proximity Read

Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Semantic proximity Read

Antitumour effect of neoantigen-reactive T cells induced by RNA mutanome vaccine in mouse lung cancerSemantic proximity Read